Skip to main content
Clinical Trials/NCT02485275
NCT02485275
Completed
Not Applicable

Stroke Imaging Package Study

Wei-Hai Xu16 sites in 1 country949 target enrollmentJuly 1, 2015

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Acute Ischemic Stroke
Sponsor
Wei-Hai Xu
Enrollment
949
Locations
16
Primary Endpoint
90-days prognosis
Status
Completed
Last Updated
7 years ago

Overview

Brief Summary

Our study aims to explore the value of new imaging technique package in predicting early neurological deterioration (END) as well as 90-day unfavorable outcome in patients with acute ischaemic stroke.

Detailed Description

1. Patients with acute ischemic stroke within 4.5-72h after onset were prospectively enrolled in our study and underwent standardized clinical and new imaging technique package assessment. 2. New imaging technique package mainly includes conventional cranial MRI (T1,T2,T2 FLAIR,DWI, and ADC), cranial magnetic resonance angiography (MRA), and intracranial vessel wall imaging (High-Resolution Magnetic Resonance Imaging,HRMRI) as well as susceptibility weighted imaging (SWI). 3. The neurofunctional fluctuation during hospitalization as well as 90-day outcomes were carefully assessed. Patients were followed up for 90-days after stroke onset. 4. Our study aims to explore the value of new imaging technique package in predicting early neurological deterioration (END) as well as 90-day unfavorable outcome in patients with acute ischaemic stroke.

Registry
clinicaltrials.gov
Start Date
July 1, 2015
End Date
November 30, 2017
Last Updated
7 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Wei-Hai Xu
Responsible Party
Sponsor Investigator
Principal Investigator

Wei-Hai Xu

Associate Professor

Peking Union Medical College Hospital

Eligibility Criteria

Inclusion Criteria

  • patients with ischemic stroke and hospitalized during 4.5-72 hours after onset , confirmed by diffusion weighted imaging (DWI).
  • patients with stable vital signs.
  • patients who have underwent thrombolytic/intravascular therapy are allowed to enroll in the study.

Exclusion Criteria

  • patients with absolute/relative contraindication to MRI (including but not confined to metal in the body and claustrophobia).
  • patients who is extremely agitated, and cannot comply with MRI exam.
  • patients who declined the consent.

Outcomes

Primary Outcomes

90-days prognosis

Time Frame: 90-days after stroke onset

90-days prognosis included two parts :1) stroke recurrence with new lesion on DWI;2) the modified Ranking Score (mRS) at 90-days after stroke onset.

early neurological deterioration within 3 weeks after stroke onset (END-3 weeks)

Time Frame: 3 weeks after stroke onset

END-3 weeks is defined as a significant neuro-functional decline \[increment of the National Institutes of Health Stroke Scale (NIHSS) ≥ 2 points \] within 3 weeks after admission.

Study Sites (16)

Loading locations...

Similar Trials